Table 1 Endocrine assessment baseline
From: Avascular femoral necrosis as part of Cushing syndrome presentation: a case report
Test | Result | Reference range |
|---|---|---|
Cortisol (after 1 mg overnight DST) | 21.5 µg/dL | < 1.8 µg/dL |
ACTH | <1.0 p/mL | < 63.3 pg/mL |
24-hour UFC | 728.9 µg/day | 36.0–137.0 µg/day |
TSH | 0.86 µUI/mL | 0.35–4.94 µUI/mL |
FT4 | 0.76 ng/dL | 0.70–1.48 ng/dL |
FT3 | 1.53 pg/mL | 1.71–3.71 pg/mL |
IGF-1 | 119 ng/mL | 57–241 ng/mL |
PRL | 11.9 ng/mL | 4.8–23.3 ng/mL |
FSH | 4.44 mUI/mL | 2.40–12.60 mUI/mL (follicular phase) |
LH | 0.53 mUI/mL | 3.50–12.50 mUI/mL (follicular phase) |
Estradiol | 10.4 pg/mL | 12.5–166 pg/mL (follicular phase) |
SHBG | 12.7 nmol/L | 26.1–110.0 nmol/L |
Total testosterone | < 0.03 ng/mL | 0.06–0.82 ng/mL |
DHEA-S | 11.3 µg/dL | 60.9–337.0 µg/dL |
δ-4-androstenedione | < 0.3 ng/mL | 0.30–3.30 ng/mL |
17-OH-Progesterone | 0.24 ng/mL | 0.6–2.6 ng/mL (follicular phase) |